CRIS Current Research Information System

LODATO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.707
NA - Nord America 3.139
EU - Europa 2.060
AF - Africa 192
Continente sconosciuto - Info sul continente non disponibili 128
SA - Sud America 111
OC - Oceania 3
Totale 9.340
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.088
VN - Vietnam 1.891
SG - Singapore 704
CN - Cina 576
GB - Regno Unito 542
SE - Svezia 283
IT - Italia 260
DE - Germania 251
HK - Hong Kong 158
FR - Francia 135
IN - India 123
UA - Ucraina 114
RU - Federazione Russa 107
IE - Irlanda 80
BR - Brasile 76
NL - Olanda 67
CI - Costa d'Avorio 59
CH - Svizzera 53
JP - Giappone 50
ZA - Sudafrica 48
KR - Corea 44
EE - Estonia 41
TG - Togo 37
BD - Bangladesh 36
FI - Finlandia 32
CA - Canada 31
JO - Giordania 27
TH - Thailandia 20
NG - Nigeria 18
BE - Belgio 17
BG - Bulgaria 17
PH - Filippine 17
PL - Polonia 17
SC - Seychelles 16
GR - Grecia 15
AR - Argentina 13
IR - Iran 10
ES - Italia 9
SA - Arabia Saudita 8
TR - Turchia 8
TW - Taiwan 8
IQ - Iraq 7
EC - Ecuador 6
MX - Messico 6
CO - Colombia 5
LT - Lituania 5
PK - Pakistan 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
JM - Giamaica 4
AU - Australia 3
CL - Cile 3
ID - Indonesia 3
AO - Angola 2
CR - Costa Rica 2
DK - Danimarca 2
HR - Croazia 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PE - Perù 2
PY - Paraguay 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BO - Bolivia 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GF - Guiana Francese 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
MT - Malta 1
NP - Nepal 1
RO - Romania 1
SV - El Salvador 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.214
Salva come PNG Salva come JPEG
Città #
Singapore 508
Southend 471
Ho Chi Minh City 436
Hanoi 389
Ashburn 345
Chandler 331
Fairfield 265
Dong Ket 242
San Jose 150
Hong Kong 146
Santa Clara 136
Houston 123
Wilmington 107
Woodbridge 100
Seattle 98
Ann Arbor 94
Princeton 89
Dublin 79
Hefei 75
Boardman 74
Beijing 73
Cambridge 69
Council Bluffs 69
Jacksonville 68
Da Nang 66
Abidjan 59
Haiphong 56
Bern 47
Westminster 46
Lauterbourg 43
Los Angeles 41
Tokyo 41
Nanjing 40
Lomé 37
Thái Nguyên 34
Padova 33
New York 32
Ha Long 31
Seoul 31
Dallas 30
Medford 30
Saint Petersburg 30
Biên Hòa 29
Munich 28
Amman 27
Buffalo 27
Milan 26
Quận Bình Thạnh 26
Hải Dương 25
Berlin 24
Dearborn 23
Helsinki 23
Bologna 22
Can Tho 22
Bắc Ninh 20
Abeokuta 18
Brussels 17
Ninh Bình 17
Shenyang 17
Vũng Tàu 17
Bremen 16
Hebei 16
São Paulo 16
Vinh 16
Florence 15
Guangzhou 15
Nanchang 15
Sofia 15
Changsha 14
Turin 14
Frankfurt am Main 13
Jinan 13
Bắc Giang 12
London 12
Falkenstein 11
Chicago 10
Falls Church 10
Jiaxing 10
Quận Phú Nhuận 10
Shanghai 10
Tianjin 10
Torino 10
Zhengzhou 10
Mülheim 9
Orem 9
Phoenix 9
Rome 9
San Diego 9
The Dalles 9
Toronto 9
Uyen Hung 9
Xi'an 9
Hangzhou 8
Lấp Vò 8
Mahé 8
Nam Định 8
Redondo Beach 8
Turku 8
Augusta 7
Haikou 7
Totale 6.108
Salva come PNG Salva come JPEG
Nome #
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence 617
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence 522
Outcomes and survival after TIPS positioning: a single center experience 409
Two cases of severe autoimmune manifestations following virological response to peginterferon alpha- 2b + ribavirin in liver transplanted patients with recurrence of chronic hepatitis C 343
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 333
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 279
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 263
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 258
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 239
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 222
Adverse effects of proton pump inhibitors. 221
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 218
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 217
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 216
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 216
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 215
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 204
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 203
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 184
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 183
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 181
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 180
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 177
Pharmacological modulation of MRP2 in primary biliary cirrhosis 175
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 167
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 167
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 166
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 166
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 164
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 160
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 158
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 157
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 157
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 156
MRP2 is upregulated by UDCA in cholestasis of pregnancy. 156
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 141
Placental MRP2 is upregulated by UDCA in cholestasis of pregnancy. 139
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 139
Modulation of placental bilirubin and bile acids transporters during cholestasis of pregnancy. 127
Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression 123
Outcomes and survival after TIPS positioning: a single center experience 122
Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence 103
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. 103
Impact of multidisciplinary discussion on pancreatic neuroendocrine tumours, experience of a tertiary centre 48
THE GASTROPACK SYSTEM, A NOVEL METHOD TO ACCESS TO GASTROENTEROLOGICAL CARE: RESULTS OF THE UPPER GASTROINTESTINAL SYMPTOM POPULATION 39
Totale 9.340
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022902 0 49 61 60 73 70 18 44 35 51 260 181
2022/20231.149 119 178 61 153 70 92 29 60 184 30 81 92
2023/2024254 13 44 13 33 18 54 9 13 26 13 9 9
2024/2025994 42 174 75 55 170 48 46 29 27 82 35 211
2025/20263.480 1.265 213 181 140 315 160 227 49 520 211 95 104
2026/2027109 42 67 0 0 0 0 0 0 0 0 0 0
Totale 9.340